Durvalumab vs Semaglutide

Durvalumab vs Semaglutide: Overview

This comparison examines the pharmacological differences between Durvalumab and Semaglutide.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Semaglutide: GLP-1 receptor agonist with enhanced albumin binding for extended action.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Semaglutide — 7 days.

Chemical Properties

Type: Durvalumab — Antibody; Semaglutide — Protein.